Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 19, 2024

SELL
$214.88 - $256.94 $214 - $256
-1 Reduced 6.67%
14 $3,000
Q3 2023

Oct 12, 2023

BUY
$211.82 - $248.24 $211 - $248
1 Added 7.14%
15 $3,000
Q2 2023

Jul 14, 2023

BUY
$205.19 - $232.99 $2,872 - $3,261
14 New
14 $3,000
Q4 2022

Jan 13, 2023

BUY
$205.95 - $280.43 $2,677 - $3,645
13 New
13 $0

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $17B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Advisor Net Financial, Inc Portfolio

Follow Advisor Net Financial, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Net Financial, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Advisor Net Financial, Inc with notifications on news.